Table of contents
Orthopedic Leaders Advice on Overcoming Fee Schedule Cuts and Declining Reimbursements
The major question for every orthopedic group leader is: Can orthopedic groups still maintain strong margins and financial stability?
Yes, but only through active adaptation. Fee schedule cuts, including the 2.83% Medicare conversion factor reduction in 2025 and the planned 2.5% efficiency adjustment for 2026, will not reverse on their own, and waiting for legislation won’t protect your margins. With reimbursement declining an average of 1.5% annually after inflation adjustment, while labor and supply costs have climbed 82% per full-time equivalent from 2013 to 2022, the financial pressure is intensifying.
Orthopedic practices must now think strategically about revenue leakage (where an estimated 80% of denials are avoidable, with 30% never being reprocessed), payer management (as prior authorization requests now average 39 per physician per week), cost control, and new payment models that enable greater financial flexibility and reimbursement control.
Declining reimbursements are not the result of one problem. As industry experts, such as Allison Farmer, CEO of EmergeOrtho, one of the largest orthopedic practices in the U.S., have recently stated, the orthopedic sector is at a crossroads. She warned that,
“If reimbursements do not significantly increase, organizations may have to begin cutting access to services, which is not the goal for any practice.”
Why Are Orthopedic Reimbursements Declining?
Let’s start with the biggest driver, the Medicare Physician Fee Schedule (MPFS) cuts. According to the American Association of Orthopaedic Surgeons (AAOS) comment letter on the 2026 Medicare Physician Fee Schedule, the conversion factor for CY 2025 included a -2.83 % cut, marking the fifth straight year of cuts. Due to the budget neutrality rule, gains in certain services must be offset by cuts in others, and procedural specialties tend to be on the losing side. This means that even as patient volumes rise with an aging Medicare population, payments per service are falling.
At the same time, operational costs have surged; labor, implants, technology investments, rent, cybersecurity requirements, and compliance demands are all rising faster than payer reimbursement rates. Yet orthopedic groups cannot simply charge more because CMS and private payer contracts lock pricing in place.
The pressure is worse in Medicare Advantage (MA) and commercial plans, which often pay below traditional Medicare rates and require more prior authorizations. MA plans introduce payment delays, administrative friction, and increasing denial risk, eroding the cash flow stability that orthopedic groups depend on.
This multifactor challenge results in revenue per case trending downward, cost per case going upward, and a widening gap that threatens financial sustainability unless actions are taken now.
What Should Orthopedic Leaders Do First to Prepare for 2026?
The fastest way to respond to reimbursement decline is to understand where the margin pressure is happening. CFOs and COOs should immediately evaluate three things:
- Which codes took the biggest hit under the 2025 fee schedule?
- Which payers are causing the most denials, delays, or underpayments?
- Which service lines have a negative contribution margin when fully costed?
Running a reimbursement audit is essential. By reviewing RVUs, conversion factors, payer mix, and case-level profitability, leadership can pinpoint where the practice is losing dollars, sometimes for years without realizing it. Groups that benchmark implant cost per case and OR utilization also tend to outperform peers financially because they catch hidden leakage early.
Once the true gaps are visible, the practice can start to act strategically rather than reactively.
Can Orthopedic Groups Control Costs Without Compromising Care?
Absolutely, and this is where operational efficiency becomes a competitive advantage. Many practices find substantial savings through:
- Implant contract standardization
- Tightening OR scheduling and block utilization
- Automated prior authorizations
- Optimized staffing mix using cross-training and scheduling analytics
Orthopedic operations leaders should use the full extent of 50+ KPIs that provide data driven answers for cost optimization without compromising care. Also, technology plays a critical role here. Front-end tools for insurance verification, scheduling, and digital intake reduce leakage and denial risk before it even hits the billing team. Meanwhile, backend analytics can flag patterns in underpayment, delayed MA reimbursements, or rising implant costs that may go unnoticed in traditional P&L reports.
The most successful orthopedic practices don’t just work harder; they work smarter, using data to uncover inefficiencies that quietly erode margins.
How Should Orthopedic Groups Approach Payer Negotiations in 2026?
The era of passive payer relationships is over. Contract leverage now depends on data-backed evidence and demonstrable efficiency. Practices that can show payer-specific denial patterns, case-level cost benchmarking, and OR utilization efficiency often gain better reimbursement terms, quality incentives, or bundled payment opportunities.
Rather than waiting for contracts to renew, many groups are launching payer performance reviews and renegotiating specific contract terms, especially around prior auth turnaround time, denied claim resolution time, and bundled orthopedic programs.
Commercial payers are willing to negotiate, but only with practices that bring data to the table.
Is Fee-for-Service Still Viable Or Should Orthopedic Groups Move Beyond It?
Fee-for-service remains dominant, but its limitations are becoming clear. Orthopedic groups are exploring:
- Bundled payments for joint replacement
- Direct-to-employer contracting
- Self-pay models for younger elective patients
- Value-based models tied to outcomes and cost efficiency
Innovative orthopedic groups are already pursuing these models to reduce payer dependency and regain pricing control. But these models require data transparency, operational readiness, and leadership alignment, which groups are well-positioned to achieve.
Your size is an advantage. You are agile enough to pivot quickly, not weighed down by hospital bureaucracy, yet large enough to invest in analytics and care coordination.
How Should Leadership Align Around Financial Resilience?
This challenge cannot be solved by a billing department alone. It must be addressed at the leadership level:
- CFOs must have real-time financial visibility
- COOs must track operational leakage
- Practice administrators must ensure payer rules are followed at the front end
- Physicians must understand the economic consequences of procedural variation
A strong orthopedic group behaves like a high-reliability organization (HRO), data-driven, collaborative, proactive, and aligned on financial stability as a shared priority.
Orthopedic Financial Stability Depends on Action, Not Hope
Fee schedule cuts are not slowing down. Payer scrutiny will only increase. Medicare Advantage enrollment is rising while reimbursement rates decline. The only groups that will thrive are those that:
- Understand exactly where financial leakage is happening
- Control cost without sacrificing care
- Use data to negotiate with payers
- Move beyond fee-for-service dependencies
- Align leadership around measurable targets
Orthopedic groups have a strategic advantage today agility. Use it now, before reimbursement models tighten further.
